(Q43559117)

24 November 2017

title

Antipsychotic prescription use and costs for persons with schizophrenia in the 1990s: current trends and five year time series forecasts (English)

1 reference

24 November 2017

0 references

B C Martin

1

1 reference

24 November 2017

L S Miller

series ordinal

2

1 reference

24 November 2017

J A Kotzan

series ordinal

3

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

24 November 2017

published in

Schizophrenia Research

1 reference

24 November 2017

volume

47

1 reference

24 November 2017

issue

2-3

1 reference

24 November 2017

page(s)

281-292

1 reference

Atypical antipsychotics: Part II: Adverse effects, drug interactions, and costs

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900108-0

7 January 2021

Costs of schizophrenia in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900108-0

7 January 2021

Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900108-0

7 January 2021

Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900108-0

7 January 2021

Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900108-0

7 January 2021

Measuring the economic costs of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900108-0

7 January 2021

The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900108-0

7 January 2021

Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900108-0

7 January 2021

The costs of schizophrenia. Assessing the burden.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900108-0

7 January 2021

Pharmacoeconomics of the new antipsychotics for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900108-0

7 January 2021

10.1016/S0920-9964(00)00108-0

Identifiers

DOI

1 reference

24 November 2017

1 reference